Community Research and Development Information Service - CORDIS

Validation of a personalised medicine tool for Multiple Myeloma that predicts treatment effectiveness in patients

From 2016-11-01 to 2019-04-30, ongoing project

Project details

Total cost:

EUR 3 755 802,50

EU contribution:

EUR 2 949 027,50

Coordinated in:

Netherlands

Call for proposal:

H2020-FTIPilot-2015-1See other projects for this call

Funding scheme:

IA - Innovation action

Objective

Coordinator

Erasmus Universitair Medisch Centrum Rotterdam
Netherlands

EU contribution: EUR 419 687,50


s Gravendijkwal
3015 CE Rotterdam
Netherlands
Activity type: Other

Participants

UNIVERSITA DEGLI STUDI DI TORINO
Italy

EU contribution: EUR 387 500


Via Giuseppe Verdi 8
10124 TORINO
Italy
Activity type: Higher or Secondary Education Establishments
SKYLINEDX B.V.
Netherlands

EU contribution: EUR 1 882 475


MARCONISTRAAT 16
3029AK ROTTERDAM
Netherlands
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
ERASMUS UNIVERSITEIT ROTTERDAM
Netherlands

EU contribution: EUR 210 615


BURGEMEESTER OUDLAAN 50
3062 PA ROTTERDAM
Netherlands
Activity type: Higher or Secondary Education Establishments
MYELOMA PATIENTS EUROPE AISBL
Belgium

EU contribution: EUR 48 750


RUE DE DAMPREMY 67 BTE 32
6000 Charleroi
Belgium
Activity type: Other
Record Number: 206290 / Last updated on: 2017-05-05